Winning Coverage for
Breakthrough Therapies
Innovation doesn’t guarantee access. Payor coverage does.
Extraordinary therapies stall when coverage criteria lags. Learn how leading manufacturers translate evidence, stakeholder experience, and demand into coverage policy - and accelerate access.
Scientific Progress Alone Doesn't Move Coverage.
Patient access depends on how well your therapy fits into how payors actually build, revise, and defend policy. Coverage accelerates when uncertainty is reduced, signals are visible, and the ask aligns with internal decision-making.
Inside the Coverage Decision: What Payors Weigh
Clinical necessity and comparative value vs standard of care
Evidence Quality policy-ready vs. case-by-case learning
Stakeholder input translated into credible, visible signals
Population impact and demand across covered lives
Understanding these factors is necessary - but insight alone doesn't change coverage.
What Actually Accelerates Access
Manufactures who succeed don't push harder on a single submission. They apply a repeatable set of moves aligned to how coverage policies evolve over time.
The Three Moves that Accelerate Coverage
(Preview - full detail in article)
1. Design evidence to resolve payor uncertainty—not just demonstrate efficacy.
2. Convert stakeholder experience into visible, decision-ready signals.
